Scribe Therapeutics, Inc. (SCTX)
18.98
-1.69
(-8.18%)
USD |
NASDAQ |
Oct 13, 14:03
Scribe Therapeutics EPS Diluted (Quarterly) : -0.3421 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3421 |
| March 31, 2026 | -0.9869 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.5231 |
| March 31, 2025 | -0.1948 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -0.6931 |
| Twist Bioscience Corp. | -0.5617 |
| Veracyte, Inc. | 0.3106 |
| Cypherpunk Technologies, Inc. | 0.1812 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.477M |
| Revenue (Quarterly) | 1.918M |
| Total Expenses (Quarterly) | 8.395M |
| Enterprise Value | 511.94M |
| Gross Profit Margin (Quarterly) | 59.07% |
| Profit Margin (Quarterly) | -337.7% |
| Earnings Yield | -10.78% |
| Normalized Earnings Yield | -10.83 |